Seth Kantor is a Rheumatology/Immunology physician affiliated with The Ohio State University. OpenAlex indexes 8 publications with 351 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3900 Stoneridge Ln
Dublin, OH 430172009
Telephone
614-798-7905Registry record last updated 7 Dec 2007.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202551 payments$17,524openpaymentsdata.cms.gov ↗
- Radius Health, Inc.Program year202511 payments
- Almatica Pharma LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
100%Other drugs affecting bone structure and mineralization83%Romosozumab-aqqg100%Part B, office-administered≥195 patientsRANK Ligand Inhibitor17%Denosumab100%Part B, office-administered≥483 patientsHormonal (systemic)
0%Parathyroid Hormone Analog0%Teriparatide67%Forteo33%Part D<11 patientsAntiparasitic
0%Antimalarial0%Hydroxychloroquine Sulfate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1990–1995 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
PubMed
2004 - A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis
Arthritis & Rheumatism
1988
Similar KOLs
Other experts from the same institution or the same specialty.
Ernest Mazzaferri, MD
The Ohio State University
Jennifer Woyach, MD
The Ohio State University
Steven Gabbe, MD
The Ohio State University
Carl Leier, MD
The Ohio State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”